Healthstream Inc Surpasses Analyst Price Target Amid Ratings

Healthstream Inc has crossed the $33.00 price target set by analysts, trading at $33.33. Investors are now evaluating whether the stock's valuation is justified, given the strong buy ratings from analysts.

Date: 05-02-2025

AI Rating: 7

Stock Performance and Analyst Target Evaluation
Healthstream Inc (HSTM) has recently crossed the average analyst 12-month target price of $33.00, currently trading at $33.33. This moment could signal a potential re-evaluation of the stock by analysts, who may either downgrade it based on valuation or raise their target price. Observing the average target fosters a "wisdom of crowds" approach and reflects collective analyst sentiment towards the stock.

The stock's movement past the average target price suggests strength in performance; however, differing analyst targets exist, with a low target of $29.00 and a high of $36.00, indicating a standard deviation of $3.605. This variance might reflect differing opinions on the company's future prospects, which is essential for investors to consider while making decisions.

Ratings Breakdown Insight
A breakdown of the recent analyst ratings shows that Healthstream has maintained three strong buy ratings and four hold ratings over the past three months, which translates to an average rating of 2.14 on a scale where 1 is Strong Buy and 5 is Strong Sell. This suggests a generally favorable outlook among the analysts covering HSTM, although no buy or sell ratings have been recorded in recent months.

Stocks: HSTM